ZGZahra Gholamnezhad

Zahra Gholamnezhad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zahra Gholamnezhad has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Mohammad Hossein Boskabady

    Applied Biomedical Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    5 shared publications
  • Mahmoud Hosseini

    Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    4 shared publications
  • Mohammad Hossein Boskabady

    Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    4 shared publications
  • Ramin Rezaee

    Applied Biomedical Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

    4 shared publications
  • Narges Kasraie

    Rosenberg School of Optometry

    3 shared publications
  • Zahra Jahangiri

    Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    3 shared publications

Latest Publications

  • Open Access

    The Prevalence of Gastrointestinal Disorders and Lifestyle Habits in Medical Students of Mashhad University of Medical Sciences: A Cross-Sectional Study

    by Soroush Yazdani, Hanieh Salmani Izadi, Seyed Mohammad Matin Alavi Dana, Ali Okati, Shayan Yaghouti, Parto Pariz, Payam Sharifan, Zahra Gholamnezhad

    Introduction: This cross-sectional study aimed to assess the prevalence of gastrointestinal symptoms among medical students at Mashhad University of Medical Sciences (MUMS) and their association with lifestyle factors. Methods: Participants completed questionnaires evaluating gastrointestinal symptoms using the Gastrointestinal Symptom Rating Scale (GSRS), physical activity using the International Physical Activity Questionnaire (IPAQ), quality of life using 36-item short form health survey (SF-36), and dietary habits. Data were collected, categorized, and analyzed statistically. Results: Three hundred ninety-eight students were selected for analysis. Most participants had no complaints of reflux (62.8%), constipation (46%), or diarrhea (64.3%), or mild symptoms of abdominal pain (64.8%) and indigestion (85.9%). A total of 96.7% had mild or no symptoms according to GSRS. Male participants had higher reflux scores, while female participants reported more abdominal pain (P<0.01). No significant correlation was found between GSRS scores and lifestyle factors. Gastrointestinal symptoms were linked to reduced quality of life and mental/physical functioning (P<0.05, P<0.01). A negative correlation existed between SF-36 physical activity scores and participant sex (P<0.05). Conclusion: The study found a low prevalence of gastrointestinal symptoms among MUMS students. Digestive symptoms may affect quality of life physically and psychologically, but the severity of the symptoms may not be the main determinant of these effects.

  • Open Access

    Cyanocobalamin (vitamin B12) ameliorates lipopolysaccharide-induced systemic and lung inflammation in rats

    by Fereshteh Asgharzadeh, Aliye Ghorbanpour, Zahra Khosravi, Rasul Saberi, Zahra Gholamnezhad

    Considering the antioxidant and immunomodulatory properties of vitamin B12, this study aimed to evaluate the effects of cyanocobalamin (vitamin B12) on systemic and lung injury markers induced by lipopolysaccharide (LPS). Forty male Wistar rats were randomly assigned to five groups: Control; LPS (1 mg/kg, intraperitoneal injection on day 3 and from days 8 to 16); and LPS treated with cyanocobalamin at doses of 0.25, 0.5, and 1 mg/kg. Cyanocobalamin was administered orally from days 1 to 16. Finally, blood and lung tissue samples were collected to evaluate systemic and lung injury markers. Total white blood cell (WBC), neutrophil, eosinophil, and monocyte counts, as well as serum interleukin-6 (IL-6) levels, were elevated in LPS group compared to control animals. Treatment with cyanocobalamin at all doses reduced total WBC, neutrophil, and lymphocyte counts relative to the LPS group, except for total WBC at the 0.5 mg/kg dose. LPS induced upregulation of nitric oxide (NO), IL-6, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), malondialdehyde (MDA), and the expression of Bax, p53, and the Bax/Bcl-2 ratio, along with histopathological injury. Conversely, it downregulated Bcl-2 expression, total thiol content, and catalase (CAT) and superoxide dismutase (SOD) activities in lung tissue compared to controls. Cyanocobalamin dose-dependently ameliorated LPS-induced lung alterations, including IL-6, TNF-α, MDA, thiol content, Bax, p53, Bax/Bcl-2 ratio expression, CAT activity, and injury score. These findings suggest that a synthetic form of vitamin B12, cyanocobalamin, ameliorates LPS-induced leukocytosis, lung inflammation, apoptosis, and oxidative stress.

  • Cedrol ameliorates lipopolysaccharide-induced systemic inflammation and lung injury in rats

    by Sepide Behrouz, Mahmoud Hosseini, Ramin Rezaee, Mohammad Hossein Boskabady, Fereshteh Asgharzadeh, Zahra Gholamnezhad


  • Open Access

    Memantine, A NMDA Receptor Inhibitor Attenuate Lipopolysaccharide-Induced Lung Inflammation and Oxidative Damage in Mice

    by Atlas Gholami, Mahmoud Hosseini, Mohammad Hossein Boskabady, Masoumeh Gharib, Zahra Gholamnezhad

    The anti-oxidative and anti-inflammatory effect of memantine (an N-methyl-D-aspartate receptor inhibitor) has been shown. Therefore, the present study aimed to evaluate the preventive effects of memantine against lipopolysaccharide (LPS)-induced sub-acute lung injury in mice. Male C57BL/6 mice (n=30) were randomized in five groups as follows: (1) control (saline containing 10% DMSO); (2) LPS (5 mg/kg, intraperitoneally); and (3, 4, and 5) LPS 5 mg/kg + memantine 5, 10, 20 mg/kg, respectively. Memantine (dissolved in 10% DMSO) was administrated orally three days before the LPS injection and continued for three days after injury induction. Finally, the levels of markers of oxidative stress, malondialdehyde (MDA), catalase (CAT) and superoxide dismutase (SOD), interleukin (IL)-1β, tumor necrosis factor-α (TNF-α), and nitric oxide (NO), were measured and histopathological changes in the lung tissue were assessed. Lipopolysaccharide (LPS) administration increased the TNF-α, IL-1β, NO, and MDA, levels, while decreasing the lung tissues activity of CAT (P< 0.05) and SOD (P< 0.001) and caused lung pathological damages. Memantine 20 mg/kg, alleviated LPS-induced injury score, reduced the lung tissue levels of TNF-α, IL-1β, MDA, and NO, and restored CAT activity (P< 0.05, P< 0.01). LPS-triggered elevation of lung injury markers including histopathological changes, inflammatory cytokines, and oxidative damage. All pathological changes were suppressed by memantine.

  • Open Access

    Effects of moderate exercise on lipopolysaccharide-induced acute lung injury and tracheal hyperresponsiveness in rats

    by Toktam Sahranavard, HamidReza Rezaei Moghaddam, Ramin Rezaee, Mohammad Hossein Boskabady, Zahra Gholamnezhad

    Aim: Assessment of the effects of moderate exercise on lipopolysaccharide (LPS)-triggered lung injury. Method: Thirty-two male Wistar rats were divided into four groups of eight as follows: (1) control; (2) LPS; (3) exercise (EX); and (4) exercise+ LPS (EX+LPS). Exercise groups were submitted to exercise (15 m/min for 30 min, 6 days/week, for a period of 8 weeks). LPS (1 mg/kg) was intraperitoneally injected on a daily basis for 5 successive days during the last week of the experiment. Ultimately, the levels of stress oxidative markers in the bronchoalveolar lavage fluid (BALF) and in lung tissues, total white blood cells (WBC) counts in the BALF, inflammatory markers in lung tissue, tracheal responsiveness to methacholine, and lung histopathological changes were assessed. Results: LPS injection increased the number of total WBC, neutrophils, eosinophils, monocytes, and lymphocytes as well as malondialdehyde (MDA) levels in the BALF, tumor necrosis factor-α (TNF-α), interleukin (IL)- 1β, and MDA in lung tissues, and tracheal responsiveness to methacholine, and caused lung pathological damages (P<0.05-P<0.001). Moderate exercise preconditioning decreased total WBC, neutrophils, eosinophils, monocytes, and lymphocytes counts in the BALF, diminished levels of TNF-α, IL-1β, and MDA in the lung, but increased thiol levels in lung tissues (P<0.05-P<0.01). Furthermore, moderate exercise alleviated tracheal hyper-responsiveness (P<0.01). Conclusion: Moderate training improved LPS-induced lung injury by attenuating lung inflammatory cytokine levels, oxidative damage, and pathological changes and tracheal hyper-responsiveness.

  • Open Access

    Impact of Endurance Exercise Training on Biomarkers of Aortic Endothelial Damage in Diabetic Rats

    by Mahtab Fouladi, Maryam Mahmoudabady, Zahra Gholamnezhad, Sadegh Shabab, Saeed Niazmand, Hossein Salmani

    Given the heightened risk of diabetes‐related cardiovascular events associated with inactivity, this study investigates the molecular mechanisms of vascular damage in streptozotocin (STZ)‐induced diabetic rats. The aim is to elucidate the impact of different exercises (interval and continuous training) and metformin on biochemical parameters, aortic injury, oxidative stress, and inflammation to provide insights into potential therapeutic interventions for diabetes‐associated vascular complications. Male Wistar rats were administered a single dose of STZ (60 mg/kg) to induce diabetes. Diabetic rats underwent either interval training or continuous training (40 min/day, 5 days/week, 6 weeks), received metformin (300 mg/kg), or a combination of metformin and exercise. After 6 weeks, biochemical parameters in serum and oxidative stress markers and mRNA expression of endothelial nitric oxide synthase (eNOS), lectin‐like oxidized low‐density lipoprotein receptor‐1 (LOX‐1), and intercellular adhesion molecule‐1 (ICAM‐1) in aorta tissue were assessed. Serum levels of fasting blood sugar (FBS), triglyceride (TG), total cholesterol (TC), low‐density lipoprotein (LDL), TG/HDL, TC/HDL, and LDL/HDL ratios were significantly reduced in all treatment groups compared to the diabetes group. Both types of exercises, metformin, and exercise+metformin combinations, significantly reduced oxidative stress by decreasing malondialdehyde (MDA) and enhancing the antioxidant status in the aortic tissue compared to the diabetic group. In addition, in exercise groups, metformin, and combination groups, the expression of eNOS was significantly elevated, while LOX‐1 and ICAM‐1 expression significantly decreased compared to the diabetic group. In most cases, the combination of exercise and metformin (especially interval training) was more effective than exercise alone. It seems that exercise along with taking metformin can be considered as a therapeutic method by improving hyperglycemia and hyperlipidemia and reducing oxidative stress and vascular inflammatory responses, leading to ameliorating biomarkers function related to endothelial damage in experimental diabetes conditions.


  • Open Access

    Therapeutic effects of Medicago sativa against cyclophosphamide-induced toxicity in rats

    by Vajihe Rouki, Mohammad Hossein Boskabady, Narges Marefati, Reyhaneh Sotoudeh, Zahra Gholamnezhad

    Objective: Medicago sativa (M. sativa) has been traditionally used for treating anemia; therefore, M. sativa hydro-ethanolic extract therapeutic effects against cyclophosphamide (CP) induced hematologic and liver toxicity were examined.Materials and Methods: Thirty male Wistar rats were randomly divided to control (saline); CP (100 mg/kg, day 1-3, subcutaneously); CP+ M. sativa 200 mg/kg (MS 200); CP+ M. sativa 400 mg/kg (MS 400); CP+ dexamethasone (0.1 mg/kg), (all groups n=6). Treated animals received M. sativa or dexamethasone by gavage from days 7-14. On days 0, 7, and 14, hematologic parameters, and on the 14th day, serum and liver tissue oxidative stress markers including nitric oxide, malondialdehyde (MDA) and total thiol levels, superoxide dismutase (SOD) and catalase (CAT) activities, serum lipids, and liver enzymes were measured.Results: Animal weight, platelet, white blood cells, and red blood cells counts, hemoglobin and hematocrit as well as thiol, SOD, and CAT activities in serum and liver tissue were significantly reduced, but serum nitric oxide, MDA, total cholesterol, triglycerides, low-density lipoproteins levels, and liver enzymes were increased in the CP group compared to the control group (p<0.05 to p<0.001). Administering M. sativa extract (400 mg/kg) significantly enhanced platelet count, and SOD and CAT activities and inhibited all of the CP toxic effects, while dexamethasone improved platelet count and oxidative stress markers compared to the CP group (p<0.05 to p<0.001).Conclusion: The extract of M. sativa (400 mg/kg) showed therapeutic effects against the CP-induced myelosuppression and thrombocytopenia and improved oxidative stress markers which were comparable to the effect of dexamethasone.


  • Medicago sativa ameliorated cyclophosphamide-induced thrombocytopenia and oxidative stress in rats

    by Zahra Gholamnezhad, Vajihe Rouki, Ramin Rezaee, Mohammad Hossein Boskabady

    Effect of Medicago sativa (MS) hydro-ethanolic extract against the cyclophosphamide (CP)-induced toxicity was evaluated in rats grouped as: Control; CP (100 mg/kg subcutaneous, day 1–3); and CP+ MS100, 200, and 400 mg/kg/day, orally for 14 days. Hematologic, lipid, hepatic and oxidative stress markers were analyzed. Platelet, WBC, RBC, Hb and Hct in the CP group were lower than the control. The MS200 and MS400 groups had lower lipids, liver enzymes, nitrite and malondialdehyde levels but higher platelet, WBC, thiol, superoxide dismutase and catalase levels than the CP group. MS ameliorated CP-induced thrombocytopenia, oxidative stress, and increases in serum lipids and hepatic enzymes.


  • Open Access

    Phytochemical Characteristics and Anti‐Inflammatory, Immunoregulatory, and Antioxidant Effects of Portulaca oleracea L.: A Comprehensive Review

    by Vahideh Ghorani, Saeideh Saadat, Mohammad Reza Khazdair, Zahra Gholamnezhad, Hesham El-Seedi, Mohammad Hossein Boskabady

    Portulaca oleracea L. (P. oleracea) or purslane is a plant from the Portulacaceae family, which is used as food and traditional medicine for various diseases. This review article provides comprehensive information on the antioxidant, immunomodulatory, and anti‐inflammatory properties of P. oleracea and its constituents. The literature survey of the different databases until the end of June 2023 was explored based on the keywords including the “P. oleracea, purslane, anti‐inflammatory, immunomodulatory, and antioxidant properties.” The plant contains flavonoids, alkaloids, terpenoids, fatty acids, vitamins, minerals, and some other compounds. The results indicated that P. oleracea and its constituents showed anti‐inflammatory and immunomodulatory properties through reduction of inflammatory mediators including interferon gama (IFN‐γ), interleukin (IL)‐10, IL‐4, tumor necrosis factor‐alpha (TNF‐α), and nitric oxide. Improvement in cytokines’ serum levels (IFN‐γ, IL‐10, and IL‐4) and increased IgG and IgM serum levels, as well as reduction of IgE, phospholipase A2, and total protein were demonstrated for P. oleracea. The plant and its constituents also improved oxidative stress by reduction of oxidant and increase of antioxidant markers. P. oleracea could be considered as an effective remedy for various inflammatory and immune diseases.


  • Open Access

    The concurrent accuracy of the modified telephone interview for cognitive status and mini-mental state examination tools in detection of cognitive impairment among older adults

    by Delara Laghousi, Nayyereh Aminisani, Seyed Morteza Shamshirgaran, Ali Javadpour, Zahra Gholamnezhad, Neda Gilani, Mohammad Asghari-Jafarabadi, Fiona Alpass

    Due to the need for face-to-face administration of many cognitive screening tests, it is not always feasible to screen large-scale samples. Objective: This study aimed to assess the discriminant validity of the Persian version of Telephone Interview for Cognitive Status (P-TICS-m) and Mini-Mental State Examination in the middle-aged Iranian population. Methods: The P-TICS-m and MMSE were administered to 210 randomly selected middle-aged community-dwelling adults who had been registered in the Neyshabur Longitudinal Study on Ageing. Participants also underwent psychological examination by two neurologists to assess cognitive impairment based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria. To evaluate the discriminant validity of P-TICS-m and MMSE with DSM-V criteria, the sensitivity, specificity, positive and negative predictive values (PPV and NPV), and positive and negative likelihood ratios (LR+ and LR−) were calculated. Results: The mean age of the participants was 59.6±6.8 years. The TICS and MMSE were highly correlated (r=0.635, p<0.001). The sensitivity, specificity, PPV, NPV, LR+, and LR− to discriminate cognitive impairment were, respectively, 83%, 92%, 68%, 96%, 10, and 0.182 for MMSE and 100%, 13%, 19%, 100%, 1.16, and 0 for TICS-m. The receiver operating characteristic curve analysis results showed no statistically significant differences between P-TICS-m and MMSE. Conclusions: Our findings indicate that the TICS-m test can be used as a screening tool instead of the MMSE. Due to the low specificity and low PPV of the TICS-m compared to MMSE, the diagnosis should be confirmed using definitive diagnostic tests when a subject is classified as having cognitive impairment.